In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database.
Journal of comparative effectiveness research(2023)
摘要
Describe the clinical and economic burden of hospitalizations for amyloid light chain (AL) amyloidosis. This retrospective analysis used nationally representative hospital discharge data (2017-2020) to report discharge status, resource use and costs for hospitalizations among patients with AL amyloidosis. Of 1341 patients identified, 92% were discharged alive and 8% experienced in-hospital death. Compared with the average US hospital stay during 2017-2019 (4.7 days, mean costs of $13,046 and mean charges of $54,496), hospital stays for AL amyloidosis were longer and costlier (9.7 days, $27,098.61, $111,233.91), especially in patients with in-hospital death (12.2 days, $44,966, $182,338.18). AL amyloidosis is associated with significant clinical and economic burden.
更多查看译文
关键词
AL amyloidosis,hospitalization,mortality
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要